NCT06589895View on ClinicalTrials.gov

Correlation Between RISANKIZUMAB's Trough Levels, Clinical and Biological Remission in Moderate to Severe Crohn's Disease: a Retrospective Multicentric Study

CompletedOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

June 1, 2021

Primary Completion Date

May 30, 2024

Study Completion Date

May 30, 2024

Conditions
Inflammatory Bowel Diseases
Trial Locations (1)

30029

Centre Hospitalier Universitaire de Nîmes, Nîmes

All Listed Sponsors
lead

Centre Hospitalier Universitaire de Nīmes

OTHER